Characterization of cryptic rearrangements, deletion, complex variants of PML, RARA in acute promyelocytic leukemia
Open Access
- 1 January 2011
- journal article
- Published by CLOCKSS Archive in Indian Journal of Human Genetics
- Vol. 17 (2) , 54-8
Abstract
Acute promyelocytic leukemia (APL) is characterized by a reciprocal translocation t(15;17)(q22;q21) leading to the disruption of Promyelocytic leukemia (PML) and Retionic Acid Receptor Alpha (RARA) followed by reciprocal PML-RARA fusion in 90% of the cases. Fluorescence in situ hybridization (FISH) has overcome the hurdles of unavailability of abnormal and/or lack of metaphase cells, and detection of cryptic, submicroscopic rearrangements. In the present study, besides diagnostic approach we sought to analyze these cases for identification and characterization of cryptic rearrangements, deletion variants and unknown RARA translocation variants by application of D-FISH and RARA break-apart probe strategy on interphase and metaphase cells in a large series of 200 cases of APL. Forty cases (20%) had atypical PML-RARA and/or RARA variants. D-FISH with PML/RARA probe helped identification of RARA insertion to PML. By application of D-FISH on metaphase cells, we documented that translocation of 15 to 17 leads to 17q deletion which results in loss of reciprocal fusion and/or residual RARA on der(17). Among the complex variants of t(15;17), PML-RARA fusion followed by residual RARA insertion closed to PML-RARA on der(15) was unique and unusual. FISH with break-apart RARA probe on metaphase cells was found to be a very efficient strategy to detect unknown RARA variant translocations like t(11;17)(q23;q21), t(11;17)(q13;q21) and t(2;17)(p21;q21). These findings proved that D-FISH and break-apart probe strategy has potential to detect primary as well as secondary additional aberrations of PML, RARA and other additional loci. The long-term clinical follow-up is essential to evaluate the clinical importance of these findings.Keywords
This publication has 24 references indexed in Scilit:
- Diagnostic utility of dual fusion PML/RARα translocation DNA probe (D-FISH) in acute promyelocytic leukemiaOncology Reports, 2007
- New highly sensitive fluorescence in situ hybridization method to detect PML/RARA fusion in acute promyelocytic leukemiaCancer Genetics and Cytogenetics, 2003
- New cytogenetic variant, insertion (15;17)(q22;q12q21), in an adolescent with acute promyelocytic leukemiaCancer Genetics and Cytogenetics, 2002
- Fluorescence in situ hybridizationCancer Genetics and Cytogenetics, 2001
- Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: result of the Randomized MRC Trial.1999
- Acute promyelocytic leukemia: All-trans retinoic acid (ATRA) along with chemotherapy is superior to ATRA aloneAmerican Journal of Hematology, 1999
- Acute promyelocytic leukemia: a curable diseaseLeukemia, 1998
- All-Trans-Retinoic Acid (ATRA): Pediatric Acute Promyelocytic LeukemiaPediatric Hematology and Oncology, 1998
- Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemia.1997
- Cytogenetic findings in patients with acute promyelocytic leukemia and a case of CML blast crisis with promyelocytic proliferationCancer Genetics and Cytogenetics, 1990